Alteration of telomeric repeat length in hepatocellular carcinoma is independent of telomerase activity

International Journal of Oncology

Volumn 11, Issue 1, 1997, Pages 139-143

  Nakashio, Ryo ^a   Kitamoto, Mikiya ^a   Nakanishi, Toshio ^a   Tahara, Hidetoshi ^a   Ide, Toshinori ^a   Asahara, Toshimasa ^a   Kajiyama, Goro ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Hepatocellular carcinoma (HCC); Telomerase; Telomere length; Terminal restriction fragment (TRF)

Indexed keywords

DNA; TELOMERASE;

ADULT; AGED; ARTICLE; CANCER SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; RESTRICTION FRAGMENT; SURVIVAL RATE; TELOMERE; TUMOR DIFFERENTIATION;

EID: 0030854632     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.11.1.139     Document Type: Article

References (11)

1. De Lange T: Activation of telomerase in a human tumor. Proc Natl Acad Sci USA 91: 2882-2885, 1994.
2. Blackburn EH: Structure and function of telomeres. Nature 350: 569-573, 1991.
3. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, Greider CW and Harley CB: Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 89: 10114-10118, 1992.
4. Harley CB: Telomere loss: mitotic clock or genetic time bomb? Mutat Res 256: 271-282, 1991.
5. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello GM, Wright WE, Weinrich SL and Shay JW: Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015, 1994.
6. Feng J, Funk WD, Wang S, Weinrich SL, Avilion AA, Chiu C, Adams RR, Chang E, Allospp RC, Yu J, Le S, West MD, Harley CB, Andrews WH, Greider CW and Villeponteau B: The RNA component of human telomerase. Science 269: 1236-1241, 1995.
7. Tahara H, Nakanishi T, Kitamoto M, Nakashio R, Shay JW, Tahara E, Kajiyama G and Ide T: Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res 55: 2734-2736, 1995.
8. Shirotani Y, Hiyama K, Ishioka S, Inyaku K, Awaya Y, Yonehara S, Yoshida Y, Inai K, Hiyama E, Hasegawa K, Inamizu T and Yamakido M: Alteration in length of telomeric repeats in lung cancer. Lung Cancer 11: 29-41, 1994.
9. Bryan TM, Englezou A, Gupta J, Bacchetti S and Reddel RR: Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 14: 4240-4248, 1995.
10. McEachern MJ and Blackburn EH: Runaway telomere elongation caused by telomerase RNA gene mutations. Nature 376: 403-409, 1995.
11. Strahl C and Blackburn EH: Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines. Mol Cell Biol 16: 53-65, 1996.